Translational Genomics Research Institute-Massachusetts Institute Of Technology

First targeted nanomedicine to enter human clinical studies

A team of scientists, engineers and physicians from Brigham and Women's Hospital (BWH), Dana-Farber Cancer Institute (DFCI), Harvard Medical School (HMS), Massachusetts Institute of Technology (MIT), BIND Biosciences, Translational Genomics Research Institute (TGen), Wayne State University Karmanos Cancer Institute, and Weill Cornell Medical College have found promising effects of a first-in-class targeted cancer drug called BIND-014 in treating solid tumors. read more..

source:http://www.worldpharmanews.com

Arthur G. James Cancer Hospital-Solove Research Institute-Ohio State University

Cancer cells send out the alarm on tumor-killing virus

Brain-tumor cells that are infected with a cancer-killing virus release a protein "alarm bell" that warns other tumor cells of the impending infection and enables them to mount a defense against the virus, according to a study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). read more..

source:http://www.worldpharmanews.com